Adult Influenza Vaccine: Safety and Clinical Effectiveness
This paper examines the influenza vaccine as a preventive measure against a contagious respiratory illness that affects millions of people globally each year. It reviews the clinical effectiveness of the vaccine across different age groups, noting that efficacy in healthy adults ranges from 40% to 60% and tends to be lower in older adults due to immunosenescence. The paper also addresses safety concerns, including mild side effects, the rare risk of Guillain-Barré Syndrome, and egg-allergy considerations. Additionally, it discusses specialized high-dose and adjuvanted formulations developed for elderly populations, the role of vaccination in chronic disease management, and the importance of public health communication in overcoming vaccine hesitancy.
- Introduction: Overview of influenza and vaccine's preventive role
- Clinical Effectiveness of the Influenza Vaccine: Efficacy rates, herd immunity, and disease burden reduction
- Safety Concerns of the Influenza Vaccine: Adverse events, GBS risk, egg allergies, and surveillance
- Promoting Health Across the Lifespan: High-dose vaccines and chronic disease management in elderly
- Conclusion: Vaccine hesitancy, communication, and lifelong immunization culture
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper balances both efficacy and safety dimensions of the influenza vaccine, giving readers a well-rounded view rather than a one-sided advocacy piece.
- It distinguishes between population subgroups — healthy adults, older adults, and those with chronic conditions — demonstrating nuanced thinking about how vaccine outcomes vary by demographic.
- Claims are consistently tied to peer-reviewed citations, lending academic credibility to each argument made throughout the discussion.
Key academic technique demonstrated
The paper consistently uses hedged language ("is believed to," "is said to," "the evidence suggests") to accurately represent the probabilistic and consensus-based nature of public health research. This technique shows awareness that vaccine effectiveness data comes from population-level studies rather than guaranteed individual outcomes — an important distinction in health sciences writing.
Structure breakdown
The paper follows a clear four-part structure: an introduction establishing the clinical significance of influenza vaccination; a section on clinical effectiveness covering efficacy rates, herd immunity, and disease burden reduction; a section on safety covering adverse events, egg allergies, and surveillance systems; and a section on lifespan health promotion focusing on high-dose vaccines and chronic disease management. The conclusion ties these threads together with a public health communication perspective on vaccine hesitancy.
Introduction
Influenza is a contagious respiratory illness caused by influenza viruses that affects millions of people globally every year and can cause morbidity and mortality among older adults and those with underlying health conditions (Javanian et al., 2021). Vaccination is considered by many in the medical community to be the best preventive measure against influenza. This discussion focuses on the influenza vaccine and examines its safety concerns and clinical effectiveness in promoting health across the lifespan, especially in adults and older populations.
References
Javanian, M., Barary, M., Ghebrehewet, S., Koppolu, V., Vasigala, V., & Ebrahimpour, S. (2021). A brief review of influenza virus infection. Journal of Medical Virology, 93(8), 4638–4646.
Koike, H., & Katsuno, M. (2021). Emerging infectious diseases, vaccines and Guillain-Barré syndrome. Clinical and Experimental Neuroimmunology, 12(3), 165–170.
Lee, J. K., Lam, G. K., Shin, T., Samson, S. I., Greenberg, D. P., & Chit, A. (2021). Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis. Vaccine, 39, A24–A35.
Marlowe, E., Pranikoff, S., Borsheim, B., Salafian, K., Halvorson, E. E., & Kram, D. E. (2022). Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates. Vaccine, 40(46), 6625–6630.
Tenforde, M. W., Chung, J., Smith, E. R., Talbot, H. K., Trabue, C. H., Zimmerman, R. K., ... & Patel, M. M. (2021). Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015–2018. Clinical Infectious Diseases, 73(3), 386–392.
Create your account
Always verify citation format against your institution’s current style guide requirements.